Dr. Benjamin Oakes, Ph.D. - CEO, Scribe Therapeutics - Engineering The Future Of Genetic Medicine Progress, Potential, and Possibilities 2 years ago Play Download
Scribe Therapeutics Stock: The 1,000% Potential of CRISPR 2.0? Dennis Kramer 1 month ago Play Download
Scribe Therapeutics (NASDAQ: SCTX) IPO Analysis | Is This Biotech IPO Worth Watching? GIST Company 2 months ago Play Download
CERDAAC Customer Testimonial: Scribe Therapeutics SIMCO Quality Calibration and Software Services 2 years ago Play Download
Scribe Therapeutics ($SCTX) director bought $15M after a 15% crash Trace Four 2 months ago Play Download
Dr. Benjamin Oakes, Ph.D. - CEO, #ScribeTherapeutics - Engineering The Future Of #Genetic #Medicine Progress, Potential, and Possibilities 2 years ago Play Download
Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes Life Science Connect 8 months ago Play Download
Founder Stories: Ben Oakes, Co-Founder and CEO of Scribe Therapeutics Axial 4 years ago Play Download
The Age of CRISPR: Engineering the Future of Genetic Medicine | Benjamin Oakes | TEDxBerkeley TEDx Talks 2 years ago Play Download
SCTX Stock Analysis Today | Scribe Therapeutics Inc Stock | Chart Analysis & Company Overview IT NEWS BIKUL 2 months ago Play Download
CRISPR Impact On Genetic Medicine 🧬 w/ Co-Founders of Scribe Therapeutics | BIOS BIOS 4 years ago Play Download
Enabling Genetic Medicine 🧬 w/ Co-Founders of Scribe Therapeutics | BIOS BIOS 4 years ago Play Download
